Lecture 3 Strachan and Read Chapters 16 & 18

Slides:



Advertisements
Similar presentations
Linkage and Genetic Mapping
Advertisements

Lecture 2 Strachan and Read Chapter 13
What if we want to know what allele(s) of beta-globin an individual has?
Kamila Balušíková.  DNA – sequence of genes, repetitive sequence of noncoding regions  RNA  Proteins gene expression.
Variants of PCR Lecture 4
Gene Therapy in Huntington’s Disease Project was done by Rejan Chin & Sharisa Ford.
Chapter 14 – The Human Genome
DNA Technology- Cloning, Libraries, and PCR 17 November, 2003 Text Chapter 20.
TOPICS IN (NANO) BIOTECHNOLOGY Lecture 7 5th May, 2006 PhD Course.
Fig 11-1 Chapter 11: recombinant DNA and related techniques.
Chapter 5: Hybridisation & applications
6.3 Advanced Molecular Biological Techniques 1. Polymerase chain reaction (PCR) 2. Restriction fragment length polymorphism (RFLP) 3. DNA sequencing.
-The methods section of the course covers chapters 21 and 22, not chapters 20 and 21 -Paper discussion on Tuesday - assignment due at the start of class.
1 Genetics Faculty of Agriculture Instructor: Dr. Jihad Abdallah Topic 13:Recombinant DNA Technology.
DNA Technology Chapter 20.
How do you identify and clone a gene of interest? Shotgun approach? Is there a better way?
Single Nucleotide Polymorphisms Mrs. Stewart Medical Interventions Central Magnet School.
Restriction Nucleases Cut at specific recognition sequence Fragments with same cohesive ends can be joined.
Module 1 Section 1.3 DNA Technology
Items for tomorrow and beyond: 1) Study/read captions for all figures within Chapter 20 2) Read Section 20.5 (applications of biotechnology) on pp
DNA Technology. Overview DNA technology makes it possible to clone genes for basic research and commercial applications DNA technology is a powerful set.
Used for detection of genetic diseases, forensics, paternity, evolutionary links Based on the characteristics of mammalian DNA Eukaryotic genome 1000x.
 DNA (gene mutations, paternity, organs compatibility for transplantations)  RNA  Proteins (gene expression)
DNA TECHNOLOGY AND GENOMICS CHAPTER 20 P
Genetic Screening. Objectives Be able to describe the processes involved in genetic screening through DNA hybridisation. Be able to describe the role.
ABC for the AEA Basic biological concepts for genetic epidemiology Martin Kennedy Department of Pathology Christchurch School of Medicine.
Using a Single Nucleotide Polymorphism to Predict Bitter Tasting Ability Lab Overview.
Human Genomics. Writing in RED indicates the SQA outcomes. Writing in BLACK explains these outcomes in depth.
6.3 Advanced Molecular Biological Techniques 1. Polymerase chain reaction (PCR) 2. Restriction fragment length polymorphism (RFLP) 3. DNA sequencing.
Chapter 10: Genetic Engineering- A Revolution in Molecular Biology.
Lecturer: David. * Reverse transcription PCR * Used to detect RNA levels * RNA is converted to cDNA by reverse transcriptase * Then it is amplified.
Polymerase Chain Reaction (PCR) Nahla Bakhamis. Multiple copies of specific DNA sequences; ‘Molecular Photocopying’
Chapter 20: DNA Technology and Genomics - Lots of different techniques - Many used in combination with each other - Uses information from every chapter.
Molecular Genetic Technologies Gel Electrophoresis PCR Restriction & ligation Enzymes Recombinant plasmids and transformation DNA microarrays DNA profiling.
DNA Technology Ch. 20. The Human Genome The human genome has over 3 billion base pairs 97% does not code for proteins Called “Junk DNA” or “Noncoding.
DNA Technology & Genomics
Using a Single Nucleotide Polymorphism to Predict Bitter Tasting Ability Lab Overview.
Chapter 14 GENETIC TECHNOLOGY. A. Manipulation and Modification of DNA 1. Restriction Enzymes Recognize specific sequences of DNA (usually palindromes)
Probes and screening for disease. Background Genetic disorders are often the result of gene mutations. People with a mutant allele often have a family.
Arun Kumar. B M.Sc 1st Year Biotechnology SSBS
Chapter 13 Nucleic Acid Biotechnology Techniques Mary K. Campbell Shawn O. Farrell Paul D. Adams University.
A Little More Advanced Biotechnology Tools
GENETIC MARKERS (RFLP, AFLP, RAPD, MICROSATELLITES, MINISATELLITES)
DNA Technology and Genomics
Restriction Fragments and Mapping
Chapter 7 Recombinant DNA Technology and Genomics
Figure 20.2 Overview of gene cloning
CHAPTER 20 PART 3: A LITTLE MORE ADVANCED BIOTECHNOLOGY TOOLS
PLANT BIOTECHNOLOGY & GENETIC ENGINEERING (3 CREDIT HOURS)
Today’s Title: CW: DNA manipulation – separating and probing
Alu insert, PV92 locus, chromosome 16
Cloning Overview DNA can be cloned into bacterial plasmids for research or commercial applications. The recombinant plasmids can be used as a source of.
Chapter 20: DNA Technology and Genomics
SOUTHERN BLOTTING Ali Zaeri Medical Genetics and diagnostic lab Lab 5.
AMPLIFYING AND ANALYZING DNA.
Chapter 20 – DNA Technology and Genomics
Single Nucleotide Polymorphisms
Chapter 14 Bioinformatics—the study of a genome
Screening a Library for Clones Carrying a Gene of Interest
Recombinant DNA Technology
CHAPTER 12 DNA Technology and the Human Genome
A Little More Advanced Biotechnology Tools
Recombinant DNA Technology
A Little More Advanced Biotechnology Tools
Polymerase Chain Reaction (PCR)
A Little More Advanced Biotechnology Tools
A Little More Advanced Biotechnology Tools
Chapter 20: DNA Technology and Genomics
SBI4U0 Biotechnology.
Presentation transcript:

Lecture 3 Strachan and Read Chapters 16 & 18 Detecting mutations Lecture 3 Strachan and Read Chapters 16 & 18

Proving it's the right gene Genetic evidence is the "gold standard" for deciding if your candidate gene is the correct one. The questions to be answered are: Is there a mutation in the gene, that affects protein structure or gene expression? Is the mutation found in patients but not healthy controls? Do some patients have a different mutation in the same gene? In the case of complex disease, this is hard to prove - because the same disease may have different genetic causes (heterogeneity)

Methods for mutation detection Deletions, insertions, or re-arrangements (>10bp) can be detected by restriction enzyme digestion, gel electrophoresis, Southern blotting and probing with the candidate gene, or by PCR of regions of the candidate gene This was used to find the mutations causing myotonic dystrophy and Huntington’s Disease

Myotonic dystrophy Autosomal dominant neuromuscular disease Main symptoms: muscle weakness, wasting, myotonia (can’t relax grip) Can be fatal in infants Affects up to 1/8000 people (commonest adult muscular dystrophy, similar number at risk Affects also eyes, endocrine organs, heart, brain “Anticipation” – earlier onset, more severe, in successive generations In 1982, mapped to chromosome 19; gene discovered in 1992

Huntington’s disease Autosomal dominant, affects 1/20000 plus more at risk Progressive brain degeneration, due to death of certain groups of neurons Onset usually late 30s, death 15 years later Symptoms: personality changes, memory loss, movement disorder (jerkiness), chronic weight loss No treatment or cure In 1983, mapped to chromosome 4; gene discovered in 1993

Detecting small mutations Small changes such as single base changes or insertions/deletions of < 10bp are harder to detect. Small changes such as single base mutations can be detected in many ways Purify DNA fragment to be analysed, usually by PCR. A label (radioactive or fluorescent) can be incorporated at this stage. You can also start with mRNA, by first reverse-transcribing it into cDNA. This saves you having to analyse all the non-coding parts of the gene (the introns) which are present in genomic DNA. Treat DNA fragment in some way, which is specific to the method being used Analyse the products by gel electrophoresis or equivalent technique

SSCP In Single-strand conformation polymorphism (SSCP) the DNA fragment is heated to denature the strands, then cooled rapidly on ice Some of the single DNA strands will form secondary structures by themselves rather than re-annealing with their complementary strand The type of secondary structure formed is determined by the base sequence, and influences the mobility of the fragment on non-denaturing acrylamide gel electrophoresis A slight difference in mobility relative to a normal control fragment indicates a mutation Quick and easy to do on a small scale

Heteroduplex analysis If a fragment is PCR-amplified from a sample of DNA that is heterozygous for a mutation, the product will contain fragments that are different at a single position in the sequence If they are denatured and renatured, they will form either perfectly-matched double stranded DNA, or "heteroduplex" DNA in which one strand is from the normal and the other from the mutant Heteroduplexes have slower mobility on agarose gel electrophoresis than perfectly-matched sequences If the sample to be tested is potentially homozygous for the mutation (e.g. in a recessive disease) it can be mixed with wild-type DNA before PCR A new method, Denaturing High-Performance Liquid Chromatography (DHPLC), uses the same principle but separates the fragments on HPLC columns (very quick and accurate)

Heteroduplex and dHPLC http://www.uni-saarland.de/fak8/huber/dhplc.htm

Direct DNA sequencing This is the slowest method, but also the most definitive The fragment is sequenced by the dideoxy method A base change is revealed as a position in the sequence ladder where there are two bases side-by-side instead of the usual one This is because the DNA template used for sequencing contained a mixture of normal and mutant sequences

1,2: SSCP. 1 is a normal sample, 2 is a mutant. 3,4,5: Heteroduplex analysis. 3, homozygous normal; 4, homozygous for a mutation; 5, heteroduplex formed by mixing normal and mutant. GATC: direct DNA sequencing. Arrow shows position of mutant base; normal allele has A, mutant has C.